IPO activity has started gaining steam after falling significantly in the first half, in line with the global trend, but it is
IPO Alert: Third Harmonic files to go public. Here’s what you need to know
Categories
Biotechnology
Jaguar Health, Inc. (JAGX) Q2 2022 Earnings Call Transcript
Jaguar Health, Inc. (NASDAQ: JAGX) Q2 2022 earnings call dated Aug. 22, 2022 Corporate Participants: Lisa Conte -- Founder & Chief Executive Officer Carol
Bio Path Holdings Inc. (BPTH) Q2 2022 Earnings Call Transcript
Bio Path Holdings Inc. (NASDAQ: BPTH) Q2 2022 earnings call dated Aug. 16, 2022 Corporate Participants: WIll O'Connor -- Managing Director Peter Nielsen -- President and
Veru Inc. (VERU) Q3 2022 Earnings Call Transcript
Veru Inc. (NASDAQ: VERU) Q3 2022 earnings call dated Aug. 11, 2022 Corporate Participants: Samuel Fisch -- Executive Director, Investor Relations & Corporate Communications
CATALYST PHARMACEUTICALS INC (CPRX) Q2 2022 Earnings Call Transcript
CATALYST PHARMACEUTICALS INC (NASDAQ: CPRX) Q2 2022 earnings call dated Aug. 10, 2022 Corporate Participants: Alicia Grande -- Chief Financial Officer Patrick J. McEnany -- Co-Founder, Chairman,
Cara Therapeutics , Inc. (CARA) Q2 2022 Earnings Call Transcript
Cara Therapeutics , Inc. (NASDAQ: CARA) Q2 2022 earnings call dated Aug. 08, 2022 Corporate Participants: Iris Francesconi -- Chief Strategy Officer and Head
FibroGen, Inc. (FGEN) Q2 2022 Earnings Call Transcript
FibroGen, Inc. (NASDAQ: FGEN) Q2 2022 earnings call dated Aug. 08, 2022 Corporate Participants: Michael Tung -- Vice President of Corporate Strategy and Investor
Moderna, Inc. (MRNA) Q1 2022 Earnings Call Transcript
Moderna, Inc. (NASDAQ: MRNA) Q1 2022 earnings call dated Aug. 03, 2022 Corporate Participants: Lavina Talukdar -- Senior Vice President and Head of Investor
Regeneron Pharmaceuticals Inc. (REGN) Q2 2022 Earnings Call Transcript
Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) Q2 2022 earnings call dated Aug. 03, 2022 Corporate Participants: Ryan Crowe -- Vice President of Investor Relations Leonard
Sage Therapeutics, Inc. (SAGE) Q2 2022 Earnings Call Transcript
Sage Therapeutics, Inc. (NASDAQ: SAGE) Q2 2022 earnings call dated Aug. 02, 2022 Corporate Participants: Helen Rubinstein -- Director of Investor Relations Barry Greene -- Chief
ImmunoGen, Inc. (IMGN) Q2 2022 Earnings Call Transcript
ImmunoGen, Inc. (NASDAQ: IMGN) Q2 2022 earnings call dated Jul. 29, 2022 Corporate Participants: Anabel Chan -- Head of Investor Relations Mark Enyedy -- President &
Infographic: Key highlights from Biogen (BIIB) Q2 2022 earnings results
Biogen Inc. (NASDAQ: BIIB) reported second quarter 2022 earnings results today. Total revenue decreased 7% year-over-year to $2.58 billion. Net income attributable
Despite generic threat, AbbVie (ABBV) remains a good long-term bet
Biopharmaceutical firm AbbVie Inc. (NYSE: ABBV) is currently at a crucial juncture as it strives to overcome the threat from generic competitors
Avid Bioservices Inc (CDMO) Q4 2022 Earnings Call Transcript
Avid Bioservices Inc (NASDAQ: CDMO) Q4 2022 earnings call dated Jun. 29, 2022 Corporate Participants: Tim Brons -- Investor Relations Nicholas Green -- President and Chief
Bio Path Holdings Inc (BPTH) Q1 2022 Earnings Call Transcript
Bio Path Holdings Inc (NASDAQ: BPTH) Q1 2022 earnings call dated May. 17, 2022 Corporate Participants: Will O'Connor -- Managing Director Peter Nielsen -- Chief Executive
Veru Inc. (VERU) Q2 2022 Earnings Call Transcript
Veru Inc. (NASDAQ: VERU) Q2 2022 earnings call dated May. 12, 2022 Corporate Participants: Samuel Fisch -- Executive Director of IR and Corporate Communications
CATALYST PHARMACEUTICALS INC (CPRX) Q1 2022 Earnings Call Transcript
CATALYST PHARMACEUTICALS INC (NASDAQ: CPRX) Q1 2022 earnings call dated May. 11, 2022 Corporate Participants: Alicia Grande -- Vice President, Chief Financial Officer &
Cara Therapeutics Inc. (CARA) Q1 2022 Earnings Call Transcript
Cara Therapeutics Inc. (NASDAQ: CARA) Q1 2022 earnings call dated May. 09, 2022 Corporate Participants: Iris Francesconi -- Interim Head of Investor Relations Christopher
Infographic: Highlights of Merck’s (MRK) Q1 2022 earnings
Pharmaceuticals company Merck & Co., Inc. (NYSE: MRK) has reported stronger-than-expected earnings and revenues for the first quarter of 2022. The positive outcome
ImmunoGen, Inc. (IMGN) Q1 2022 Earnings Call Transcript
ImmunoGen, Inc. (NASDAQ: IMGN) Q1 2022 earnings call dated May. 06, 2022 Corporate Participants: Courtney O'Konek -- Senior Director of Corporate Communications Mark Enyedy -- President
Biogen’s (BIIB) long-term prospects look intact despite Alzheimer’s drug setback
Biogen Inc. (NASDAQ: BIIB) is currently going through a difficult phase as the biotechnology firm’s main products face stiff competition and the